Oral Semaglutide vs. Injections

Semaglutide used to mean a weekly shot. Now there are two FDA-approved semaglutide pills: Rybelsus for type 2 diabetes and, since late 2025, the Wegovy pill for weight management. If you are trying to choose between a daily tablet and a weekly injection, this guide lays out the real differences.

Key takeaways

• Semaglutide comes as a weekly injection (Ozempic, Wegovy) or a daily tablet (Rybelsus, Wegovy pill).
• The FDA approved the Wegovy pill in December 2025 as the first oral GLP-1 for weight management.
• Tablets must be taken on an empty stomach with a small amount of water, then you wait before eating, drinking or other pills.
• In trials, the Wegovy pill produced weight loss in a similar range to the injection, with similar side effects.
• The best choice depends on your routine, comfort with needles, coverage and your prescriber's advice.

Same medicine, different delivery

The active ingredient is the same: semaglutide, a GLP-1 receptor agonist. Read semaglutide explained for how it works.

The hard part about a peptide pill is the stomach. Stomach acid and enzymes break peptides down, and very little gets into the blood. Oral semaglutide tablets include an absorption enhancer that helps protect the drug and move it across the stomach lining. Even so, only a small fraction is absorbed, which is why tablet doses are much higher numbers than injection doses and why the timing rules matter so much.

The products at a glance

Another option is Foundayo (orforglipron), a daily GLP-1 pill from Eli Lilly approved in April 2026. It is a different molecule, not semaglutide, and its label does not require taking it apart from food or water.

How to take oral semaglutide

The Wegovy label gives specific instructions for the tablet. Rybelsus has similar rules. In short:

1. Take it first thing in the morning on an empty stomach.
2. Swallow it whole with no more than 4 ounces of plain water. No coffee, juice or other drinks.
3. Do not split, crush or chew it.
4. Wait at least 30 minutes before eating, drinking anything else or taking other oral medicines.

Many people keep the tablet and a small glass by the bed so it is the first thing they do. A reminder on your phone or in the PepSteady app helps make it automatic.

Results from the trials

In the OASIS 4 trial, 307 adults with obesity or overweight took the Wegovy pill or placebo for 64 weeks. Among people who stayed on treatment, average weight loss was 16.6% with the pill versus 2.7% with placebo. About one in three lost 20% or more of their body weight.

For comparison, the Wegovy injection produced average losses in a similar range in its own trials. Because these were separate studies with different people, they are not a perfect head-to-head comparison. The FDA label for the pill says its safety profile is similar to the injection.

Side effects

Side effects are largely the same for both forms. The most common are nausea, vomiting, diarrhea, constipation and belly discomfort, especially after starting or increasing a dose. Both forms carry the same boxed warning about thyroid C-cell tumors and the same warnings about pancreatitis, gallbladder problems, dehydration and others.

A few points are specific to the pill:

• Taking it with food or waiting longer than 30 minutes can change how much you absorb. One expert noted that more absorption may mean more side effects, so follow the label timing.
• Because it must be taken apart from other pills, people on thyroid medicine or other morning medicines should ask their pharmacist how to schedule everything.

See common GLP-1 side effects for ways people manage symptoms.

Missed doses are handled differently

The rules differ by form. For the Wegovy tablet, the label says to skip a missed dose and take the next one the following day. For the weekly injection, the rule depends on how many days remain until the next dose. Our post on missed GLP-1 doses covers this in detail. When in doubt, ask your pharmacist.

Pros and cons

Daily tablet

• No needles, no sharps disposal, no refrigeration of pens in daily use.
• Easy to travel with.
• Must be taken every day, with strict empty-stomach timing.
• A busy morning can make the 30-minute wait hard.

Weekly injection

• One dose a week, no daily timing rules around food.
• Prefilled pens are simple to use.
• Requires injections and sharps disposal.
• Pens need proper storage, and a missed week matters more.

Questions to ask your prescriber

• Is the pill or the shot a better fit for my health goals and other medicines?
• What does my insurance cover?
• How would switching forms affect my dose plan?
• How should I time my other morning medicines?

The bottom line

Oral and injectable semaglutide contain the same medicine and work the same way. The pill trades needles for a strict daily morning routine, and trial results for weight loss fall in a similar range. The right choice is the one you can take correctly and consistently, chosen with your prescriber.

Sources

• Wegovy prescribing information, injection and tablets (FDA, 06/2026)
• FDA approves Wegovy pill, the first oral GLP-1 to treat obesity (Healio)
• FDA approves orforglipron, an oral GLP-1 for adults with obesity (Healio)
• FDA expands semaglutide label to reduce cardiovascular risk in type 2 diabetes (AJMC)

Frequently asked questions